<SEC-DOCUMENT>0001104659-24-082619.txt : 20240725
<SEC-HEADER>0001104659-24-082619.hdr.sgml : 20240725
<ACCEPTANCE-DATETIME>20240725151826
ACCESSION NUMBER:		0001104659-24-082619
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20240725
DATE AS OF CHANGE:		20240725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMTECH TELECOMMUNICATIONS CORP /DE/
		CENTRAL INDEX KEY:			0000023197
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				112139466
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280839
		FILM NUMBER:		241141600

	BUSINESS ADDRESS:	
		STREET 1:		305 N 54TH STREET
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85226
		BUSINESS PHONE:		4803332200

	MAIL ADDRESS:	
		STREET 1:		305 N 54TH STREET
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85226

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMTECH INC
		DATE OF NAME CHANGE:	19870503

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMTECH TELECOMMUNICATIONS CORP
		DATE OF NAME CHANGE:	19831215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMTECH LABORATORIES INC
		DATE OF NAME CHANGE:	19780425
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2420033d1_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Filed Pursuant to Rule 424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Registration No. 333-280839</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 1,435,884 shares of Common Stock underlying
the Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="tm2419253d1_s1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Comtech Telecommunications Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus relates to the resale from time
to time, by the selling stockholders (the &ldquo;Selling Stockholders&rdquo;) identified in this prospectus under the caption &ldquo;Selling
Stockholders,&rdquo; of up to 1,435,884 shares of common stock (the &ldquo;Warrant Shares&rdquo;), par value $0.10 per share (the &ldquo;Common
Stock&rdquo;), which the selling stockholders may acquire upon the exercise of outstanding warrants (the &ldquo;Warrants&rdquo;).</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We issued the Warrants to the Selling Stockholders
in a private placement concurrent with the entry into our Credit Facility (as defined herein). Each Warrant will have an exercise price
of $0.10 per share of Common Stock. The Warrants will expire on or prior to the close of business on June&nbsp;17, 2031.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The closing of the issuance and sale of the Warrants
was consummated on June&nbsp;17, 2024.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Selling Stockholders of the securities and
any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby
on the principal trading market or any other stock exchange, market or trading facility on which the securities are traded or in private
transactions. These sales may be at fixed or negotiated prices. See &ldquo;Plan of Distribution&rdquo; in this prospectus for more information.
We will not receive any proceeds from the resale or other disposition of the Common Stock by the Selling Stockholders. However, we will
receive the proceeds of any cash exercise of the Warrants. See &ldquo;Use of Proceeds&rdquo; beginning on page&nbsp;8 and &ldquo;Plan
of Distribution&rdquo; beginning on page&nbsp;11 of this prospectus for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Common Stock is listed on the Nasdaq Stock
Market LLC under the symbol &ldquo;CMTL.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On July&nbsp;22, 2024, the last reported sale
price of our Common Stock was $3.09 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>Investing in our securities involves a high
degree of risk. See &ldquo;<U><A HREF="#a_003">Risk Factors</A></U>&rdquo; beginning on page&nbsp;4 of this prospectus and under similar headings in the other
documents that are incorporated by reference into this prospectus for a discussion of information that should be considered in connection
with an investment in our securities.</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of this prospectus. Any representation to the contrary is a criminal offense. The securities are not being offered in any
jurisdiction where the offer is not permitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is July 23, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 93%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: right"><B><U>Page</U></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_001">About This Prospectus</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_001">1</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_002">Prospectus Summary</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_002">2</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003">Risk Factors</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_003">4</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_004">Cautionary Note Regarding Forward-Looking Statements</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_004">6</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005">Market,&nbsp;Industry And Other Data</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_005">8</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_006">Use of Proceeds</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_006">8</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007">Market Price of Our Common Stock and Related Stockholder Matters</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_007">8</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_008">Private Placement of Warrants</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_008">9</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009">Selling Stockholders</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_009">9</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_010">Plan of Distribution</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_010">11</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011">Description of Capital Stock</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_011">12</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_012">Legal Matters</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_012">17</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013">Experts</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_013">17</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_014">Where You Can Find Additional Information</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_014">18</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_015">Material Changes</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_015">18</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_016">Incorporation of Certain Information by Reference</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_016">18</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->)</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_001"></A>About
This Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should rely only on the information provided
in or incorporated by reference in this prospectus, or in a related free writing prospectus, or documents to which we otherwise refer
you. We have not authorized anyone else to provide you with different information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have not authorized any dealer, agent or other
person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus
or any related free writing prospectus. You must not rely upon any information or representation not contained or incorporated by reference
in this prospectus or any related free writing prospectus. This prospectus and any related free writing prospectus, if any, do not constitute
an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor
do this prospectus and any related free writing prospectus, if any, constitute an offer to sell or the solicitation of an offer to buy
securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should
not assume that the information contained in this prospectus and any related free writing prospectus, if any, is accurate on any date
subsequent to the date set forth on the front of such document or that any information we have incorporated by reference is correct on
any date subsequent to the date of the document incorporated by reference, even though this prospectus and any related free writing prospectus
is delivered or securities are sold on a later date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have not done anything that would permit this
offering or possession or distribution of this prospectus or any free writing prospectus in any jurisdiction where action for that purpose
is required, other than in the United States. You are required to inform yourself about and to observe any restrictions relating as to
this offering and the distribution of this prospectus and any such free writing prospectus outside the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among
the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations,
warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should
not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_002"></A>Prospectus
Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-indent: 0.5in">This summary highlights certain
information about us, this offering and information appearing elsewhere in this prospectus and in the documents we incorporate by
reference in this prospectus. This summary is not complete and does not contain all of the information that you should consider
before investing in our securities. After you carefully read this summary, to fully understand our Company and this offering and its
consequences to you, you should read this entire prospectus, including the information referred to under the heading &ldquo;Risk
Factors&rdquo; in this prospectus, as well as the other documents that we incorporate by reference into this prospectus, including
our financial statements and the notes to those financial statements, which are incorporated herein by reference from our Annual
Report on Form&nbsp;10-K for the year ended July&nbsp;31, 2023 (our &ldquo;Annual Report on Form&nbsp;10-K&rdquo;), filed with the
SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/23197/000002319723000048/cmtl-20230731.htm">October&nbsp;12,
2023</A>, our Quarterly Report on Form&nbsp;10-Q for the three month period ended October&nbsp;31, 2023, filed with the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/23197/000002319723000070/cmtl-20231031.htm">December&nbsp;7,
2023</A>, our Quarterly Report on Form&nbsp;10-Q for the three month period ended January&nbsp;31, 2024, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/23197/000002319724000034/fy24q2form_finalforwebsi.htm">March&nbsp;18,
2024</A> (as amended on
<A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/23197/000002319724000041/cmtl-20240131.htm">March&nbsp;22, 2024</A>) and our Quarterly Report on Form&nbsp;10-Q for the three month period ended April&nbsp;30, 2024, filed with
the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/23197/000002319724000080/cmtl-20240430.htm">June&nbsp;18,
2024</A> (collectively, our &ldquo;Quarterly Reports on Form&nbsp;10-Q&rdquo;). See &ldquo;Where You Can Find More
Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-indent: 0.5in">In this prospectus, unless context requires otherwise,
references to &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; or &ldquo;the Company&rdquo; refer to Comtech Telecommunications
Corp., a Delaware corporation and its consolidated subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt"><B>Comtech Telecommunications Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt"><I>Company Overview</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-indent: 0.5in">Founded in 1967, we are a leading global provider
of next-generation 911 emergency systems and secure wireless and satellite communications technologies. This includes the critical communications
infrastructure that people, businesses, and governments rely on when durable, trusted connectivity is required, no matter where they
are &ndash; on land, at sea, or in the air &ndash; and no matter what the circumstances &ndash; from armed conflict to a natural disaster.
Our solutions are designed to fulfill our customers&rsquo; needs for secure wireless communications in the most demanding environments,
including those where traditional communications are unavailable or cost-prohibitive, and in mission-critical and other scenarios where
performance is crucial. We anticipate future growth in our business due to a trend of increasing demand for global voice, video and data
usage in recent years, upgraded ground stations and related services resulting from the large quantities of satellites anticipated to
be launched for new Low Earth orbit (&ldquo;LEO&rdquo;) and Medium Earth orbit (&ldquo;MEO&rdquo;) constellations, digitization and virtualization
of modems, increased demand for troposcatter solutions for primary or backup communications, enhanced location positioning combined with
data-rich geospatial intelligence, the ongoing 911 upgrade cycle across the United States and the growth of 988 networks. We provide
our solutions to both commercial and governmental customers and manage our business through two reportable operating segments: (i)&nbsp;Satellite
and Space Communications and (ii)&nbsp;Terrestrial and Wireless Networks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-indent: 0.5in">Satellite and Space Communications is organized
into three technology areas: satellite modem technologies and amplifier technologies, troposcatter and satellite communications solutions,
and space components and antennas. This segment offers customers: satellite ground station technologies, services and system integration
that facilitate the transmission of voice, video and data over GEO (Geostationary Earth orbit), MEO and LEO satellite constellations,
including traveling wave tube power amplifiers, modems, VSAT (Very-Small-Aperture Terminal) platforms and frequency converters; satellite
communications and tracking antenna systems, including high precision full motion fixed and mobile X/Y tracking antennas, radio frequency
feeds, reflectors and radomes; over-the-horizon microwave equipment that can transmit digitized voice, video, and data over distances
up to 200 miles using the troposphere and diffraction, including the Comtech COMET (Compact-Over-the-Horizon Mobile Expeditionary Terminal);
and procurement and supply chain management of high reliability electrical, electronic and electromechanical parts for satellite, launch
vehicle and manned space applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: left; text-indent: 0.5in">Terrestrial and Wireless
Networks is organized into&nbsp;three&nbsp;service areas: next generation 911 and call delivery, Solacom call handling solutions, and
trusted location and messaging solutions. This segment offers customers: SMS text to 911 services, providing alternate paths for individuals
who need to request assistance (via text messaging) a method to reach Public Safety Answering Points (&ldquo;PSAPs&rdquo;), next generation
911 solutions, providing emergency call routing, location validation, policy-based routing rules, logging and security functionality;
Emergency Services IP Network transport infrastructure for emergency services communications and support of next generation 911 services;
call handling applications for PSAPs; wireless emergency alerts solutions for network operators; and software and equipment for location-based
and text messaging services for various applications, including for public safety, commercial and government services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt"><B>Company Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: left; text-indent: 0.5in">We are incorporated in the state of Delaware.
Our principal executive offices are located at 305 N 54th Street, Chandler Arizona 85226 and our telephone number is (480) 333-2200.
We maintain a website at <I>www.comtech.com</I>. The information contained on our website is not incorporated by reference into this
prospectus and you should not consider any information contained on, or accessible through, our website as part of this prospectus or
in deciding whether to purchase any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; width: 47%; padding-left: 10pt"><B>Common Stock offered by us</B></TD>
    <TD STYLE="padding-right: 10pt; width: 53%">1,435,884 shares of Common Stock issuable upon exercise of the
    Warrants.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; padding-left: 10pt"><B>Use of proceeds</B></TD>
    <TD STYLE="padding-right: 10pt">We will not receive any proceeds from the Common Stock offered by the Selling
    Stockholders under this prospectus. However, we will receive the proceeds of any cash exercise of the Warrants. We intend to use
    the net proceeds from any cash exercise of the Warrants for working capital and general corporate purposes. See &ldquo;Use of Proceeds.&rdquo;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; padding-left: 10pt"><B>Market for Common Stock</B></TD>
    <TD STYLE="text-align: left; padding-right: 10pt">Our Common Stock is listed on The Nasdaq Stock Market LLC under the symbol
    &ldquo;CMTL.&rdquo; On July&nbsp;22, 2024, the last reported sale price of our Common Stock was $3.09 per share.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 10pt; padding-left: 10pt"><B>Risk Factors</B></TD>
    <TD STYLE="padding-right: 10pt">See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;4 and the other information
    included in this prospectus for a discussion of factors you should carefully consider before investing in our securities.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: left; text-indent: 0.5in">The number of shares of our Common Stock to be
outstanding after this offering is based on the 28,493,857 shares of our Common Stock outstanding as of June&nbsp;30, 2024, and excludes
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left">22,369,947 shares of common stock issuable upon the conversion
of outstanding Series&nbsp;B-1 Convertible Preferred Stock, par value $0.10 per share (the &ldquo;Series&nbsp;B-1 Convertible Preferred
Stock&rdquo;);</TD>
</TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.75in"></TD><TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left">1,435,884 shares of Common Stock issuable
                                            upon exercise of the Warrants, with an exercise price of $0.10 per share;</TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.75in"></TD><TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left">1,657,854 shares of common stock issuable
                                            upon the vesting and conversion of outstanding performance shares, restricted stock units,
                                            restricted stock, share units and other stock-based awards; and</TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.75in"></TD><TD STYLE="text-align: left; width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left">141,790 shares of common stock issuable
                                            upon the vesting and exercise of outstanding stock options at a weighted average exercise
                                            price of&thinsp;$20.61 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_003"></A>Risk
Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investing in our securities involves a high
degree of risk. In addition to the other information included or incorporated by reference in this prospectus, you should carefully consider
the risks described below and in the section titled &ldquo;Risk Factors&rdquo; in our Annual Report on Form&nbsp;10-K for our most recent
fiscal year filed with the SEC, subsequent Quarterly Reports on Form&nbsp;10-Q, and in other reports we file with the SEC that are incorporated
by reference herein, before making an investment decision. The risks and uncertainties described therein and below could materially adversely
affect our business, operating results and financial condition, as well as cause the value of our securities to decline. You may lose
all or part of your investment as a result. You should also refer to the other information contained in this prospectus or incorporated
by reference herein, including our financial statements and the notes to those statements, and the information set forth under the caption
 &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo; Our actual results could differ materially from those anticipated
in these forward-looking statements as a result of certain factors, including the risks mentioned below. Forward-looking statements included
in this prospectus are based on information available to us on the date hereof, and all forward-looking statements in documents incorporated
by reference are based on information available to us as of the date of such documents. We disclaim any intent to update any forward-looking
statements. The risks described below and contained in our Annual Report on Form&nbsp;10-K and Quarterly Reports on Form&nbsp;10-Q are
not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect
our business operations.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Relating to Our Common Stock and Other Securities:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>There are a large number of shares of Common Stock underlying
our outstanding Series&nbsp;B-1 Convertible Preferred Stock, stock-based awards issued to employees and Warrants, and the sale of these
shares may depress the market price of our Common Stock and cause immediate and substantial dilution to our existing stockholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of June&nbsp;30, 2024, we had 28,493,857
shares of Common Stock issued and outstanding, outstanding shares of Series&nbsp;B-1 Convertible Preferred Stock convertible into
22,369,947 shares of Common Stock, outstanding stock-based awards convertible into 1,799,644 shares of Common Stock, and outstanding
Warrants to purchase 1,435,884 shares of Common Stock. The issuance of shares upon conversion, vesting or exercise of these
instruments will cause immediate and substantial dilution to our stockholders and any sale thereof may depress the market price of
our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our stock price is volatile.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The stock market in general and the stock prices
of technology-based companies, in particular, experience extreme volatility that often is unrelated to the operating performance of any
specific public company. The market price of our common stock has fluctuated significantly in the past and is likely to fluctuate significantly
in the future as well. Factors that could have a significant impact on the market price of our stock include, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">strategic transactions, such as acquisitions
                                            and divestures by us and our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our ability to successfully integrate
                                            and manage recent acquisitions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our issuance of potentially dilutive
                                            equity or equity-type securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our issuance of debt;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our ability to successfully access
                                            equity and debt capital markets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">future announcements concerning us
                                            or our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">shareholder activism involving our
                                            common stock, board of directors (our &ldquo;Board of Directors&rdquo;) or corporate governance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">receipt or non-receipt of substantial
                                            orders for products and services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">quality deficiencies in services or
                                            products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">results of technological innovations
                                            and new commercial products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in recommendations of securities
                                            analysts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">government regulations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in the status or outcome of
                                            government audits;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">proprietary rights or product or patent
                                            litigation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in U.S. government policies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in economic conditions generally,
                                            particularly in the terrestrial and wireless networks and satellite and space communications
                                            markets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in securities market conditions,
                                            generally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in prevailing interest rates;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">changes in the status of litigation
                                            and legal matters (including changes in the status of export matters);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">cyber attacks;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">energy blackouts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">acts of terrorism or war;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">inflation or deflation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">rumors or allegations regarding our
                                            financial disclosures or practices; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">potential resurgences of the COVID-19
                                            or similar pandemics.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Shortfalls in our sales or
earnings in any given period relative to the levels expected by securities analysts could immediately, significantly and adversely affect
the trading price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Shares eligible for future sale may adversely
affect our common stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Sales of our Common Stock or other securities
(including securities convertible into our Common Stock) in the public or private market, or the perception that these sales may occur,
could cause the market price of our common stock to decline. This could also impair our ability to raise additional capital through the
sale of our equity securities. Under our certificate of incorporation, we are authorized to issue up to 100,000,000 shares of common
stock and 2,000,000 shares of preferred stock and we are authorized to convert our authorized preferred stock into common stock. We cannot
predict the size of future issuances of our common stock or other securities or the effect, if any, that future sales and issuances of
our common stock and other securities would have on the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Future issuances of our shares of common
stock could dilute your ownership interest in Comtech and reduce the market price of our shares of common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to potential issuances of our shares
of common stock associated with acquisitions, in the future, we may issue additional securities to raise capital. We may also acquire
interests in other companies by using a combination of cash and our common stock or just our common stock. We may also issue securities
convertible into, or exercisable for, our common stock. Any of these events may dilute a stockholder&rsquo;s ownership interest in Comtech
and have an adverse impact on the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_004"></A>Cautionary
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain statements contained or incorporated by
reference in this prospectus are considered forward-looking statements (within the meaning of the Private Securities Litigation Reform
Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) and Section&nbsp;21E of the
Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;)) concerning our business, results of operations, economic
performance and/or financial condition, based on management&rsquo;s current expectations, plans, estimates, assumptions, statements concerning
the future of our industry, product development, business strategy, continued acceptance of our products, market growth, dependence on
significant customers and projections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any statements contained or incorporated by reference
in this prospectus that are not statements of historical fact may be deemed forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Forward-looking statements can be identified by
words such as: &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo;
 &ldquo;expect,&rdquo; &ldquo;future,&rdquo; &ldquo;goal,&rdquo; &ldquo;outlook,&rdquo; &ldquo;intend,&rdquo; &ldquo;likely,&rdquo; &ldquo;may,&rdquo;
 &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;seek,&rdquo; &ldquo;should,&rdquo;
 &ldquo;strategy,&rdquo; &ldquo;target,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; and similar references to future periods. Examples
of forward-looking statements include, among others, statements we make regarding our future performance and financial condition, plans
to address our ability to continue as a going concern, plans and objectives of our management and our assumptions regarding such future
performance, financial condition, and plans and objectives that involve certain significant known and unknown risks and uncertainties
and other factors not under our control which may cause our actual results, future performance and financial condition, and achievement
of our plans and objectives of our management to be materially different from the results, performance or other expectations implied
by these forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Forward-looking statements speak only as of the
date they are made, and we undertake no obligation to update any forward-looking statement in light of new information or future events,
although we intend to continue to meet our ongoing disclosure obligations under the U.S. securities laws and other applicable laws. Forward-looking
statements are subject to change and may be affected by risks and uncertainties and other factors, most of which are difficult to predict
and are generally beyond our control. These factors include, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>our ability to access capital and liquidity so that we are able
                                            to continue as a going concern;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>our ability to successfully implement changes in our executive
                                            leadership;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left">the possibility that the expected synergies and benefits from
                                            acquisitions and/or restructuring activities will not be fully realized, or will not be realized
                                            within the anticipated time periods;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the risk that acquired businesses will not be integrated successfully;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the possibility of disruption from acquisitions or dispositions,
                                            making it more difficult to maintain business and operational relationships or retain key
                                            personnel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the risk that we will be unsuccessful in implementing our &ldquo;One
                                            Comtech&rdquo; transformation and integration of individual businesses into two segments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the risk that we will be unsuccessful in implementing a tactical
                                            shift in our Satellite and Space Communications segment away from bidding on large commodity
                                            service contracts and toward pursuing contracts for our niche products and solutions with
                                            higher margins;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the nature and timing of our receipt of, and our performance
                                            on, new or existing orders that can cause significant fluctuations in net sales and operating
                                            results;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the timing and funding of government contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>adjustments to gross profits on long-term contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>risks associated with international sales;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>rapid technological change;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>evolving industry standards;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>new product announcements and enhancements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>changing customer demands and/or procurement strategies and our
                                            ability to scale opportunities and deliver solutions to current and prospective customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>changes in prevailing economic and political conditions, including
                                            as a result of Russia&rsquo;s military incursion into Ukraine, the Israel-Hamas war and attacks
                                            in the Red Sea region;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>changes in the price of oil in global markets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>changes in prevailing interest rates and foreign currency exchange
                                            rates;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>risks associated with our legal proceedings, customer claims
                                            for indemnification, and other similar matters;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>risks associated with our obligations under our Credit Facility;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>risks associated with our large contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>risks associated with supply chain disruptions; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>other risks, uncertainties and factors included or incorporated
                                            by reference in this prospectus, including those set forth under &ldquo;Risk Factors&rdquo;
                                            and those included under the heading &ldquo;Risk Factors&rdquo; in our Annual Report on Form&nbsp;10-K
                                            and our Quarterly Reports on Form&nbsp;10-Q.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additional factors could cause our business outlook,
actual financial condition or results to differ materially from those expressed in, or implied by, the forward-looking statements, and
therefore you should not place too much reliance on them. These factors include, among others, those described herein, under &ldquo;Risk
Factors&rdquo; in this prospectus and the risks described in our other filings with the SEC, including our Annual Report on Form&nbsp;10-K,
which are incorporated by reference in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is not possible to predict or identify all
such factors, and therefore the factors that are noted are not intended to be a complete discussion of all potential risks or uncertainties
that may affect forward-looking statements. If these or other risks and uncertainties materialize, or if the assumptions underlying any
of the forward-looking statements prove incorrect, our actual performance and future actions may be materially different from those expressed
in, or implied by, such forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_005"></A>Market,&nbsp;Industry
And Other Data</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Market data and certain industry data and forecasts
used in, or incorporated by reference in, this prospectus were obtained from sources we believe to be reliable, including market research
databases, publicly available information, reports of governmental agencies and industry publications and surveys. We have relied on
certain data from third-party sources, including internal surveys, industry forecasts and market research, which we believe to be reliable
based on our management&rsquo;s knowledge of the industry. Forecasts are particularly likely to be inaccurate, especially over long periods
of time. In addition, we do not necessarily know what assumptions regarding general economic growth were used in preparing the third-party
forecasts we cite. Statements as to our market position are based on the most currently available data. While we are not aware of any
misstatements regarding the industry data presented in this prospectus and the documents incorporated by reference into this prospectus,
our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the
heading &ldquo;Risk Factors&rdquo; in this prospectus and the documents incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>Use
of Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will not receive any proceeds from the sale
of the Warrant Shares by the Selling Stockholders. However, we will receive proceeds from the exercise of the Warrants by the Selling
Stockholders to the extent they are exercised for cash. We estimate that the maximum proceeds that we may receive from the exercise of
the Warrants, assuming all the Warrants are exercised at their exercise price of $0.10, will be $143,588. We do not know, however, whether
any of the Warrants will be exercised or, if any of the Warrants are exercised, when they will be exercised. It is possible that the
Warrants will expire and never be exercised. There are circumstances under which the Warrants may be exercised utilizing net share settlement
(&ldquo;Net Share Settlement&rdquo;). In these circumstances, even if the Warrants are exercised, we may not receive any proceeds, or
the proceeds that we do receive may be significantly less than what we might expect. We intend to use the aggregate net proceeds from
the exercise of the Warrants for general corporate purposes, including working capital. The Selling Stockholders will pay any expenses
incurred by the Selling Stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the Selling Stockholders
in disposing of its shares of Common Stock. We will bear all other costs, fees and expenses incurred in effecting the registration of
the shares covered by this prospectus, including, without limitation, all registration fees and fees and expenses of our counsel and
our accountants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_007"></A>Market
Price of Our Common Stock and Related Stockholder Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Market Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Common Stock is listed on The Nasdaq Stock
Market LLC under the symbol &ldquo;CMTL.&rdquo; A description of our Common Stock is set forth under the heading &ldquo;Description of
Capital Stock&rdquo; beginning on page&nbsp;12 of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The last reported sale price for our Common Stock
on July&nbsp;22, 2024 was $3.09 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Holders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of June&nbsp;30, 2024, we had approximately
323 record holders of our Common Stock and 9 record holders of our Series&nbsp;B-1 Convertible Preferred Stock. The number of record
holders was determined from the records of our transfer agent and does not include beneficial owners of our Common Stock whose shares
are held in the names of various security brokers, dealers, and registered clearing agencies. The transfer agent of our Common Stock
is Equiniti Trust Company, LLC. The transfer agent and registrar&rsquo;s address is 6201 15th Ave, Brooklyn, NY 11219.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dividend Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the third quarter of fiscal 2023, our Board
of Directors, together with management, adjusted the Company&rsquo;s capital allocation plans and determined to forgo a common stock
dividend, thereby increasing our financial flexibility. Future common stock dividends, if any, remain subject to compliance with financial
covenants under our Credit Facility, as well as approval from our Board of Directors and certain voting rights of holders of our Series&nbsp;B-1
Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_008"></A>Private
Placement of Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June&nbsp;17, 2024, the Company entered into
a Credit Agreement, dated as of June&nbsp;17, 2024, among Comtech Telecommunications Corp., the lenders party thereto, TCW Asset Management
Company LLC, as agent, and Wingspire Capital LLC, as revolving agent (the &ldquo;Credit Facility&rdquo;). The Credit Facility provides
a senior secured loan facility consisting of: (i)&nbsp;a $162.0 million term loan and (ii)&nbsp;an asset-based revolving credit facility
with revolving commitments in an aggregate principal amount of $60.0 million, which is subject to certain borrowing base limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Credit Facility, the Company
issued the Warrants to the Selling Stockholders, which entitle the Selling Stockholders to purchase from the Company 1,435,884 shares
of the Common Stock, at any time and from time to time after June&nbsp;17, 2024 and on or prior to the close of business on June&nbsp;17,
2031 (the &ldquo;Expiration Date&rdquo;), at an exercise price of $0.10 per share, subject to certain adjustments. The Warrants are exercisable
until the Expiration Date, at the election of the holder, either in full or in part, for cash or by Net Share Settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon a refinancing resulting in the payment in
full of all Term Loan Obligations (as defined in the Credit Facility) on or before the relevant maturity date, each of the Selling Stockholders
shall have the right (a &ldquo;Put Right&rdquo;) to sell, and, upon exercise by any Selling Stockholder of its Put Right, the Company
shall have the obligation to purchase for cash, up to 50% of the Warrants held by such Selling Stockholder at a price per share equal
to 90% of the 30-day volume-weighted average price of the Common Stock calculated as of the date of exercise of the Put Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the terms of the Warrants, we agreed
to file a registration statement providing for the resale by the Selling Stockholders of the Warrant Shares within 30 calendar days from
the date of the issuance of the Warrants. We agreed to use commercially reasonable efforts to cause such registration statement to become
effective as soon as practicable thereafter and to keep such registration statement continuously effective until the earlier of (1)&nbsp;the
date that the respective Selling Stockholder no longer owns any Warrants or Warrant Shares and (2)&nbsp;the date on which all Warrant
Shares held by a holder may be sold pursuant to Rule&nbsp;144 without regard to any volume or manner of sale restrictions, assuming all
Warrants held by such holder are exercised on a Net Share Settlement basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_009"></A>Selling
Stockholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Common Stock being offered by the Selling
Stockholders are those issuable to the Selling Stockholders, upon exercise of the Warrants. For additional information regarding the
issuances of the Warrants, see &ldquo;Private Placement of Warrants&rdquo; above. We are registering the Warrant Shares in order to permit
the Selling Stockholders to offer the shares for resale from time to time. In addition to entering into the Credit Facility with us and
the ownership of the shares of Common Stock and the Warrants, the Selling Stockholders have not had material relationships with us within
the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The table below lists the Selling Stockholders
and other information regarding the beneficial ownership of the shares of Common Stock by each of the Selling Stockholders. The second
column lists the number of shares of Common Stock beneficially owned by each Selling Stockholder, based on its ownership of the shares
of Common Stock and, as of June&nbsp;30, 2024, assuming exercise of the Warrants held by the Selling Stockholders on that date. The third
and fourth columns assume the sale of all Warrant Shares offered by the Selling Stockholders pursuant to this prospectus. The third column
lists the Warrant Shares offered by this prospectus by the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the terms of the Warrants,
this prospectus generally covers the resale of the maximum number of Warrant Shares issuable upon exercise of the Warrants. The Selling
Stockholder may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: -0.125in; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name of Selling Stockholders</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Shares<BR> Owned prior<BR> to Offering<SUP>(1)</SUP></B></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Shares<BR> Offered by<BR> this<BR> Prospectus<SUP>(2)</SUP></B></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares<BR> Owned<BR> after<BR> Offering</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Percentage of<BR> Shares<BR> Beneficially<BR> Owned after<BR> Offering<SUP>(3)</SUP></B></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font-size: 10pt; text-align: left; padding-left: 0in">Clover Private Credit Opportunities Origination II LP<SUP>(4)</SUP></TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">111,237</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">111,237</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0in">Clover Private Credit Opportunities Origination (Levered) II LP<SUP>(5)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">95,548</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">95,548</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0in">Maple Hill, LLC<SUP>(6)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">265,904</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">265,904</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0in">TCW Rescue Financing Fund II LP<SUP>(7)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">726,806</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">726,806</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0in">Trifolium O SPE LLC<SUP>(8)</SUP></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">236,389</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">236,389</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Represents Warrants to purchase up to an aggregate amount of 1,435,884
                                            shares of Common Stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Represents Warrant Shares issuable upon exercise of the Warrants
                                            as of June&nbsp;30, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Percentages are based on 28,493,857 shares of Common Stock outstanding
                                            as of June&nbsp;30, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>Consists of 111,237 Warrant Shares underlying Warrants issued on
                                            June&nbsp;17, 2024. The securities are directly held by Clover Private Credit Opportunities
                                            Origination II LP, a Delaware limited partnership. UBS Asset Management (Americas) LLC (&ldquo;UBS
                                            Asset Management&rdquo;) is the investment manager of Clover Private Credit Opportunities
                                            Origination II LP and accordingly has voting control and investment discretion over the securities
                                            described herein held by the fund. Baxter Wasson and Rodrigo Trelles (&ldquo;Mr.&nbsp;Wasson&rdquo;
                                            and &ldquo;Mr.&nbsp;Trelles&rdquo;), co-Managing Directors of Clover Private Credit Opportunities
                                            Origination II LP, also have voting control and investment discretion over the securities
                                            described herein held by Clover Private Credit Opportunities Origination II LP. As a result,
                                            each of UBS Asset Management and Mr.&nbsp;Wasson and Mr.&nbsp;Trelles may be deemed to have
                                            beneficial ownership (as determined under Section&nbsp;13(d)&nbsp;of the Exchange Act) of
                                            the securities described herein held by Clover Private Credit Opportunities Origination II
                                            LP. The address of Clover Private Credit Opportunities Origination II LP is c/o UBS Asset
                                            Management (Americas) LLC, as investment manager, One North Wacker Drive, 31<SUP>st</SUP>
                                            Flr, Chicago,&nbsp;IL 60606.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>Consists of 95,548 Warrant Shares underlying Warrants issued on
                                            June&nbsp;17, 2024. The securities are directly held by Clover Private Credit Opportunities
                                            Origination (Levered) II LP, a Delaware limited partnership. UBS Asset Management (Americas)
                                            LLC (&ldquo;UBS Asset Management&rdquo;) is the investment manager of Clover Private Credit
                                            Opportunities Origination (Levered) II LP and accordingly has voting control and investment
                                            discretion over the securities described herein held by the fund. Baxter Wasson and Rodrigo
                                            Trelles (&ldquo;Mr.&nbsp;Wasson&rdquo; and &ldquo;Mr.&nbsp;Trelles&rdquo;), co-Managing Directors
                                            of Clover Private Credit Opportunities Origination (Levered) II LP, also have voting control
                                            and investment discretion over the securities described herein held by Clover Private Credit
                                            Opportunities Origination (Levered) II LP. As a result, each of UBS Asset Management and
                                            Mr.&nbsp;Wasson and Mr.&nbsp;Trelles may be deemed to have beneficial ownership (as determined
                                            under Section&nbsp;13(d)&nbsp;of the Exchange Act) of the securities described herein held
                                            by Private Credit Opportunities Origination (Levered) II LP. The address of Clover Private
                                            Credit Opportunities Origination (Levered) II LP is c/o UBS Asset Management (Americas) LLC,
                                            as investment manager, One North Wacker Drive, 31st Flr, Chicago,&nbsp;IL 60606.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(6)</TD><TD>Consists of 265,904 Warrant Shares underlying Warrants issued on
                                            June&nbsp;17, 2024. The securities are directly held by Maple Hill, LLC, a Kansas limited
                                            liability company. The address of Maple Hill, LLC is 1 SW Security Benefit Place, Topeka,
                                            KS 66636.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(7)</TD><TD>Consists of 726,806 Warrant Shares underlying Warrants issued on
                                            June&nbsp;17, 2024. The securities are directly held by TCW Rescue Financing Fund II LP,
                                            a Delaware limited partnership. The address of TCW Rescue Financing Fund II LP is 515 South
                                            Flower Street, Los Angeles, CA 90071.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(8)</TD><TD>Consists of 236,389 Warrant Shares underlying Warrants issued on
                                            June&nbsp;17, 2024. The securities are directly held by Trifolium O SPE LLC, Delaware limited
                                            liability company. UBS Asset Management (Americas) LLC (&ldquo;UBS Asset Management&rdquo;)
                                            is the investment manager of Trifolium O SPE LLC and accordingly has voting control and investment
                                            discretion over the securities described herein held by the fund. Baxter Wasson and Rodrigo
                                            Trelles (&ldquo;Mr.&nbsp;Wasson&rdquo; and &ldquo;Mr.&nbsp;Trelles&rdquo;), co-Managing Directors
                                            of Trifolium O SPE LLC, also have voting control and investment discretion over the securities
                                            described herein held by Trifolium O SPE. As a result, each of UBS Asset Management and Mr.&nbsp;Wasson
                                            and Mr.&nbsp;Trelles may be deemed to have beneficial ownership (as determined under Section&nbsp;13(d)&nbsp;of
                                            the Exchange Act) of the securities described herein held by Trifolium O SPE. The address
                                            of Trifolium O SPE LLC is c/o UBS Asset Management (Americas) LLC, as investment manager,
                                            One North Wacker Drive, 31st Flr, Chicago,&nbsp;IL 60606.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_010"></A>Plan
of Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Selling Stockholder and any of their pledgees,
assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal trading
market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales
may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>ordinary brokerage transactions and transactions in which the
                                            broker-dealer solicits purchasers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>block trades in which the broker-dealer will attempt to sell the
                                            securities as agent but may position and resell a portion of the block as principal to facilitate
                                            the transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>purchases by a broker-dealer as principal and resale by the broker-dealer
                                            for its account;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>an exchange distribution in accordance with the rules&nbsp;of
                                            the applicable exchange;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>privately negotiated transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>settlement of short sales;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>in transactions through broker-dealers that agree with the Selling
                                            Stockholders to sell a specified number of such securities at a stipulated price per security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>through the writing or settlement of options or other hedging
                                            transactions, whether through an options exchange or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>a combination of any such methods of sale; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Selling Stockholders may also sell securities
under Rule&nbsp;144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Broker-dealers engaged by the Selling Stockholders
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders
(or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except
as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission
in compliance with FINRA Rule&nbsp;2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule&nbsp;2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If at the time of any offering made under this
prospectus a member of FINRA participating in the offering has a &ldquo;conflict of interest&rdquo; as defined in FINRA Rule&nbsp;5121
(&ldquo;Rule&nbsp;5121&rdquo;), that offering will be conducted in accordance with the relevant provisions of Rule&nbsp;5121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Common Stock is listed the Nasdaq Stock Market
LLC under the symbol &ldquo;CMTL.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the sale of the securities
or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions,
which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders
may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers
that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers
or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other
financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may
resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Selling Stockholders and any broker-dealers
or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities
Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale
of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling
Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with
any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company is required to pay certain fees and
expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders
against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We agreed to keep this prospectus effective until
the earlier of (a)&nbsp;the date that no Selling Stockholder owns any resale securities covered hereby and (b)&nbsp;the date on which
all of the resale securities may be sold pursuant to Rule&nbsp;144 without regard to any volume or manner of sale restrictions. The resale
securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In
addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale
in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under applicable rules&nbsp;and regulations under
the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities
with respect to the Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.
In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules&nbsp;and regulations
thereunder, including Regulation M, which may limit the timing of purchases and sales of the Common Stock by the Selling Stockholders
or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need
to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule&nbsp;172
under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_011"></A>Description
of Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description of our capital stock
is intended as a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Restated
Certificate of Incorporation (which we refer to as our &ldquo;charter&rdquo;), our Certificate of Designations of the Series&nbsp;B-1
Convertible Preferred Stock (the &ldquo;Certificate of Designations&rdquo;), our Third Amended and Restated By-Laws (the &ldquo;Bylaws&rdquo;),
and to the applicable provisions of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;). Each of the charter, the Certificate
of Designations and the Bylaws are included as an exhibit to the Registration Statement on Form&nbsp;S-1 of which this prospectus forms
a part. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete
description, you should refer to the charter, the Certificate of Designations and the Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our charter authorizes 100,000,000 shares of common
stock, $0.10 par value per share, and 2,000,000 shares of preferred stock, $0.10 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Split-Segment; Name: 002 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Common Stock Outstanding</I>. As of June&#8239;30,
2024, we had 28,493,857 shares of Common Stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Voting Rights.&#8239;</I>Each holder of our Common
Stock is entitled to one vote for each share of Common stock on all matters submitted to a vote of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Dividend Rights.&#8239;</I>Holders of our Common
Stock are entitled to receive, as and when declared by our Board of Directors, dividends payable either in cash or in property, including
securities of our Company, out of assets of our Company that are legally available therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Rights upon Liquidation.&#8239;</I>Holders of
our Common Stock are entitled to share pro rata, upon any liquidation, dissolution or winding up of our Company, in all remaining assets
available for distribution to stockholders after payment of or provision for our liabilities and the liquidation preference of any of
our outstanding preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Preemptive Rights.&#8239;</I>Holders of our Common
Stock have no preemptive rights to purchase, subscribe for or otherwise acquire any unissued or treasury shares or other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As discussed in more detail below, we are authorized
under our charter to issue up to 2,000,000 shares of preferred stock. We have currently designated two series of our preferred stock:
(1)&#8239;200,000 shares of our preferred stock designated as Series&#8239;A Junior Participating Cumulative Preferred Stock, none of which
are outstanding, and (2)&#8239;Series&#8239;B-1 Convertible Preferred Stock, 171,827.05 shares of which are currently outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Blank Check Preferred Stock</I>. Under our charter,
our Board of Directors has the authority, without stockholder approval, to designate one or more series of preferred stock, to issue shares
of preferred stock in such series up to the maximum number of shares of the relevant series of preferred stock authorized, and to determine
the preferences, rights, privileges, qualifications, restrictions and limitations of any such series, including the number of shares constituting
any such series and the designation of such series, dividend rights, voting rights, the rights and terms of conversion, the rights and
terms of redemption, the terms of any sinking fund, retirement fund or purchase fund to be provided with such series and liquidation preferences.
Acting under this authority, our Board of Directors could designate and issue a series of preferred stock with preferences, rights, privileges,
qualifications, restrictions or limitations, and adopt a stockholder rights plan, having the effect of discriminating against an existing
or prospective holder of securities as a result of such stockholder beneficially owning or commencing a tender offer for a substantial
amount of our common stock. One of the effects of authorized but unissued and unreserved shares of capital stock may be to render more
difficult or discourage an attempt by a potential acquirer to obtain control of our Company by means of a merger, tender offer, proxy
contest or otherwise, and thereby protect the continuity of the Company&rsquo;s management. The issuance of such shares of capital stock
may have the effect of delaying, deferring or preventing a change in control of the Company without any further action by our stockholders.
We have no present intention to adopt a stockholder rights plan, but could do so without stockholder approval at any future time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Series&#8239;A Junior Participating Cumulative
Preferred Stock.&#8239;</I>As of the date of this prospectus, we have designated 200,000 shares of our preferred stock as Series&#8239;A
Junior Participating Cumulative Preferred Stock, par value $0.10 per share, none of which are outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Series&#8239;B-1 Convertible Preferred Stock.&#8239;</I>As
of the date of this prospectus, we have designated 171,827.05 shares of our preferred stock as Series&#8239;B-1 Convertible Preferred Stock,
par value $0.10 per share, and currently have 171,827.05 of such shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Designation of
Series&#8239;B-1 Convertible Preferred Stock.</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series&#8239;B-1 Convertible Preferred Stock
ranks senior to the shares of the Common Stock, with respect to the payment of dividends and the distribution of assets upon a liquidation,
dissolution or winding up of the Company. As of June&#8239;17, 2024, the liquidation preference of the Series&#8239;B-1 Convertible Preferred
Stock was $178,112,483.49. Holders of the Series&#8239;B-1 Convertible Preferred Stock will be entitled to a cumulative dividend (the &ldquo;Dividend&rdquo;)
at the rate of 9.00% per annum, compounding quarterly, paid-in-kind, or 7.75% per annum, compounding quarterly, paid in cash, at the Company&rsquo;s
election. For any quarter in which the Company elects not to pay the Dividend in cash with respect to a share of <FONT STYLE="background-color: white">Series&#8239;B-1
Convertible Preferred Stock</FONT>, such Dividend will become part of the liquidation preference of such share, as set forth in the Certificate
of Designations. In addition, no dividend or other distribution on the Common Stock will be declared or paid on the Common Stock unless,
at the time of such declaration and payment, an equivalent dividend or distribution is declared and paid on the <FONT STYLE="background-color: white">Series&#8239;B-1
Convertible Preferred Stock </FONT>(the &ldquo;Participating Dividend&rdquo;), provided that in the case of any such dividend in the form
of cash, in lieu of a cash payment, such Participating Dividend will become part of the liquidation preference of the shares of <FONT STYLE="background-color: white">Series&#8239;B-1
Convertible Preferred Stock</FONT>, as set forth in the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Conversion Rights
and Mandatory Redemption.</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">The Series&#8239;B-1
Convertible Preferred Stock is convertible into shares of Common Stock at the option of the holders thereof at any time. At any time after
July&#8239;22, 2027, the Company has the right to mandatorily convert the Series&#8239;B-1 Convertible Preferred Stock, subject to certain
restrictions based on the price of the Common Stock in the preceding thirty (30) consecutive trading days. The conversion price for the
shares of Series&#8239;B-1 Convertible Preferred Stock is $7.99 as of the date hereof, subject to certain adjustments set forth in the
Certificate of Designations (as adjusted, the &ldquo;Conversion Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Voting&#8239;and
Consent Rights.</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">Holders of
the Series&#8239;B-1 Convertible Preferred Stock are entitled to vote with the holders of the Common Stock on an as-converted basis. Holders
of the Series&#8239;B-1 Convertible Preferred Stock are entitled to a separate class vote with respect to, among other things, amendments
to the Company&rsquo;s organizational documents that have an adverse effect on the </FONT>Series&#8239;B-1 Convertible Preferred Stock<FONT STYLE="background-color: white">,
authorizations or issuances of securities of the Company (other than the issuance of, in the aggregate, up to $50,000,000 of shares of
Common Stock in qualified offerings), the payment of dividends, related party transactions, repurchases or redemptions of securities of
the Company, dispositions of businesses or assets, the incurrence of indebtedness and amendments to the Credit Facility on terms and conditions
that, taken as a whole, (A)&#8239;are materially different from the existing Credit Facility or (B)&#8239;adversely affect the ability of
the Company to perform its obligations in connection with an optional repurchase of the </FONT>Series&#8239;B-1 Convertible Preferred Stock<FONT STYLE="background-color: white">,
in each case, subject to the exceptions and qualifications set forth in the Certificate of Designations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Repurchase Rights.</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each holder of Series&#8239;B-1 Convertible Preferred
Stock will have the right to require the Company to repurchase its shares of Series&#8239;B-1 Convertible Preferred Stock either (a)&#8239;on
or after October&#8239;31, 2028 or (b)&#8239;upon the consummation of an Asset Sale (as defined in the Certificate of Designations) meeting
certain criteria, in either case, at a price and on the terms set forth in the Certificate of Designations. The Company will have the
right to repurchase all, or less than all, of the shares of Series&#8239;B-1 Convertible Preferred Stock upon the consummation of an Asset
Sale meeting the same criteria, at a price and on the terms set forth in the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, each holder of Series&#8239;B-1 Convertible
Preferred Stock will have the right to cause the Company to repurchase its shares of Series&#8239;B-1 Convertible Preferred Stock in connection
with a Change of Control (as defined in the Certificate of Designations), at a price and on the terms set forth in the Certificate of
Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Right to Nominate
Director.</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For so long as the initial investors (the &ldquo;Investors&rdquo;)
(or their permitted transferees) own beneficially and of record an amount of Series&#8239;B-1 Convertible Preferred Stock with an aggregate
liquidation preference equal to at least $25,000,000 (including the liquidation preference of any shares of Series&#8239;B-1 Convertible
Preferred Stock previously held that were subsequently converted into shares of common stock for so long as the Investors (or their permitted
transferees) continue to own beneficially and of record such shares of common stock), the Investors representing at least a majority of
the outstanding shares of Series&#8239;B-1 Convertible Preferred Stock then outstanding have the right to nominate one person to serve
on the Board of Directors (such nominee, the &ldquo;Series&#8239;B-1 Convertible Preferred Stock Nominee&rdquo;, and such director, the
 &ldquo;Series&#8239;B-1 Convertible Preferred Stock Director&rdquo;).<FONT STYLE="background-color: white">&#8239;For so long as the right
to nominate one person to serve on the Board of Directors continues to be satisfied based on conditions outlined above, the Company shall
nominate the Series&#8239;B-1 Convertible Preferred Stock Nominee for election (or re-election, as applicable) as a director at the end
of each term of the Preferred Stock Director as part of the slate proposed by the Company that is included in the proxy statement (or
consent solicitation or similar document) of the Company relating to the election of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Standstill</U>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">Until the
earliest to occur of (a)&#8239;January&#8239;22, 2025, with respect to clause (2)&#8239;below and, otherwise, January&#8239;22, 2026, (b)&#8239;the
occurrence of an Insolvency Proceeding (as defined in the Credit Facility) and (c)&#8239;certain Events of Default (as defined in the Credit
Facility), subject to certain qualifications, the Investors will be subject to certain standstill restrictions pursuant to which the Investors
will be restricted, among other things and subject to certain customary exceptions, from (1)&#8239;acquiring more than a specified amount
of the Company&rsquo;s outstanding Common Stock or securities exchangeable for or convertible into the Common Stock, (2)&#8239;entering
into any derivative or other convertible instruments, hedging contracts or other derivative securities or similar instruments related
to the purchase or sale of Common Stock, (3)&#8239;making, participating in or encouraging any proxy solicitation or submitting any shareholder
proposal to the Company, (4)&#8239;publicly proposing any change of control or other material transaction involving the Company, (5)&#8239;encouraging
or entering into any agreements with any person with respect to any of the foregoing, (6)&#8239;purchasing, selling or otherwise trading
debt securities of the Company if as a result such Investor would beneficially own 19.99% of the Company&rsquo;s outstanding debt securities
or (7)&#8239;taking any action that would require the Company to make a public announcement regarding any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white"><I><U>Transfer Restrictions.</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Until the earlier of (a)&#8239;January&#8239;22,
2025 and (b)&#8239;termination of the standstill provisions (as described above), the Investors will be restricted from transferring the
Series&#8239;B-1 Convertible Preferred Stock, subject to certain specified exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this prospectus, we have outstanding
1,435,884 Warrants to purchase an aggregate of 1,435,884 shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Duration and Exercise</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants will have an exercise price of $0.10
per share of Common Stock and are exercisable at any time and from time to time after June&#8239;17, 2024 and on or prior to the close
of business on June&#8239;17, 2031. The Warrants are exercisable, at the election of the holder, either in full or in part, for cash or
by Net Share Settlement. The exercise price is subject to adjustment in connection with (i)&#8239;stock splits, dividends or distributions
or other similar transactions, (ii)&#8239;the issuance of rights or warrants to holders of the Common Stock, and (iii)&#8239;any distributions
of assets, including cash, stock or other assets or property, to holders of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Liquidity Event</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with any recapitalization, reorganization,
reclassification, consolidation, merger, or other transaction, which, in each case, is effected in such a way that all of the holders
of Common Stock are entitled to receive consideration with respect to or in exchange for Common Stock (other than a transaction that triggers
an adjustment) (a &ldquo;Liquidity Event&rdquo;), each Warrant holder will have the right to receive, upon exercise of such Warrants,
such consideration as would have been issued or payable in such Liquidity Event (if such Warrant holder had exercised such Warrant immediately
prior to such Liquidity Event) with respect to or in exchange, as applicable, for the number of Common Stock that would have been issued
upon exercise of such Warrants, if such Warrants had been exercised immediately prior to the occurrence of such Liquidity Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Repurchase Right</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon a refinancing resulting in the payment in
full of all relevant obligations on or before the relevant maturity date, each of the Selling Stockholders shall have the right (a &ldquo;Put
Right&rdquo;) to sell, and, upon exercise by any Selling Stockholder of its Put Right, the Company shall have the obligation to purchase
for cash, up to 50% of the Warrants held by such Selling Stockholder at a price per share equal to 90% of the 30-day volume-weighted average
price of the Common Stock calculated as of the date of exercise of the Put Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Transferability</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the terms of the Warrants and
subject to certain registration requirements, a Warrant may be transferred at the option of the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Fractional Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No fractional Warrant Shares, or scrip of any fractional
Warrant Shares, will be issued upon the exercise of the Warrants. If any fraction of a share of Common Stock be issuable on the exercise
of any Warrant, the holder will be entitled to receive a cash payment equal to the Market Price (as defined in the Warrant) less the exercise
price of such fractional share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Trading Market</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There is no established trading market for the
Warrants, and we do not expect a market to develop. We do not intend to apply for a listing for the Warrants on any securities exchange
or other nationally recognized trading system. Without an active trading market, the liquidity of the Warrant will be limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Rights as a Shareholder</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Warrants or
by virtue of the holders&rsquo; ownership of shares of Common Stock, the holders of Warrants do not have the rights or privileges of holders
of our shares of Common Stock, including any voting rights, until such Warrant holders exercise their warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Registration Rights</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the terms of the Warrants, we agreed
to file a registration statement providing for the resale by the Selling Stockholders of the Warrant Shares within 30 calendar days from
the date of the issuance of the Warrants. We agreed to use commercially reasonable efforts to cause such registration statement to become
effective as soon as practicable thereafter and to keep such registration statement continuously effective until the earlier of (1)&#8239;the
date that the respective Selling Stockholder no longer owns any Warrants or Warrant Shares and (2)&#8239;the date on which all Warrant
Shares held by a holder may be sold pursuant to Rule&#8239;144 without regard to any volume or manner of sale restrictions, assuming all
Warrants held by such holder are exercised on a Net Share Settlement basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Certain Provisions of Delaware Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the provisions of Section&#8239;203
of the DGCL, an anti-takeover law. In general, Section&#8239;203 of the DGCL provides that, except in certain limited circumstances, a
corporation shall not engage in any &ldquo;business combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a period of three
years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved
in a prescribed manner. A &ldquo;business combination&rdquo; includes mergers, asset sales and other transactions resulting in a financial
benefit to the interested stockholder. Subject to certain exceptions, for purposes of Section&#8239;203 of the DGCL, an &ldquo;interested
stockholder&rdquo; is a person who, together with affiliates, owns, or within three years did own, 15% or more of the corporation&rsquo;s
voting stock. This provision could have the effect of delaying or preventing a change in control of our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liability of Directors and Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As permitted by Delaware law, our charter contains
a provision that eliminates the personal liability of the directors to us and our stockholders for monetary damages for breaches of fiduciary
duties as directors, except that such provision does not apply to any breach that involves:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>a breach of a director&rsquo;s duty of loyalty to our company&#894;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>any act or omission not in good faith or which involves intentional misconduct or a knowing violation of law&#894;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>a transaction from which the director derives an improper personal benefit&#894; or</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the payment of dividends or the approval of stock repurchases or redemptions that are unlawful under the DGCL.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our by-laws provide that we shall indemnify (a)&#8239;any
person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether
civil, criminal, administrative or investigative (other than an action by or in the right of our company) by reason of the fact that he
is or was one of our directors, officers or employees, or is or was serving at our request as a director, officer or employee of another
corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines
and amounts paid in settlement, actually and reasonably incurred by him or her in connection with such action, suit or proceeding, provided
such person acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was illegal, and (b)&#8239;any person
who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by us or in our name
to procure a judgment in its favor by reason of the fact that he or she is or was one of our directors, officers or employees, or is or
was serving at our request as a director, officer or employee of another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by him or her in connection with the defense or settlement
of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our
best interests and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall
have been adjudged to be liable for negligence or misconduct in the performance of his or her duty to us unless and only to the extent
that the Court of Chancery of Delaware or the court in which such action or suit was brought shall determine upon application that, despite
the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity
for such expenses which the Court of Chancery of Delaware or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the issuer pursuant to the foregoing provisions,
or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_012"></A>Legal
Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The validity of the issuance of our securities
offered in this prospectus will be passed upon for us by Paul, Weiss, Rifkind, Wharton&#8239;&amp; Garrison LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_013"></A>Experts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The financial statements and the related financial
statement schedule of Comtech Telecommunications Corp. as of July&#8239;31, 2023 and 2022, and for each of the three years in the period
ended July&#8239;31, 2023, incorporated by reference in this Registration Statement and the effectiveness of Comtech Telecommunications
Corp.&rsquo;s internal control over financial reporting have been audited by Deloitte&#8239;&amp; Touche LLP, an independent registered
public accounting firm, as stated in their reports. Such financial statements and financial statement schedule are incorporated by reference
in reliance upon the reports of such firm given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_014"></A>Where
You Can Find Additional Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have filed with the SEC a Registration Statement
on Form&#8239;S-1 under the Securities Act with respect to the securities offered by this prospectus. This prospectus, which constitutes
a part of the registration statement, does not contain all of the information set forth in the registration statement, as permitted by
the rules&#8239;and regulations of the SEC. For further information with respect to us and our securities, we refer you to the registration
statement, including the exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the
contents of any contract or any other document are not necessarily complete. If a contract or document has been filed as an exhibit to
the registration statement, please see the copy of the contract or document that has been filed. Each statement in this prospectus relating
to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit. The SEC also maintains an Internet website
that contains the registration statement of which this prospectus forms a part, as well as the exhibits thereto. These documents, along
with future reports, proxy statements and other information about us, are available at the SEC&rsquo;s website, www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the information and reporting
requirements of the Exchange Act, and, in accordance with this law, file periodic reports and other information with the SEC. These periodic
reports and other information are available at the SEC&rsquo;s website, www.sec.gov. We also maintain a website at <I>www.comtech.com</I>.
You may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished
to, the SEC. Information contained on our website is not a part of this prospectus, and the inclusion of our website address in this prospectus
is an inactive textual reference only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_015"></A>Material
Changes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_016"></A>Incorporation
of Certain Information by Reference</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
into this prospectus the information in documents we file with it, which means that we can disclose important information to you by referring
you to those documents. The information incorporated by reference is considered to be a part of this prospectus. Any statement contained
in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes
of this prospectus to the extent that a statement contained in or omitted from this prospectus or any accompanying prospectus supplement
modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We incorporate by reference the documents listed
below; provided, however, we are not incorporating by reference any information furnished (but not filed) under Item 2.02 or Item 7.01
of any Current Report on Form&#8239;8-K:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD>Our Annual Report on Form&#8239;10-K for the fiscal year ended July&#8239;31, 2023 filed with the SEC on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/23197/000002319723000048/cmtl-20230731.htm">October&#8239;12, 2023</A>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD>Our Quarterly Reports on Form&#8239;10-Q for the three month periods ended (i)&#8239;April&#8239;30, 2024, as filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319724000080/cmtl-20240430.htm" STYLE="-sec-extract: exhibit">June&#8239;18, 2024</A>, (ii)&#8239;January&#8239;31, 2024, as filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319724000034/fy24q2form_finalforwebsi.htm" STYLE="-sec-extract: exhibit">March&#8239;18, 2024</A> (as amended on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319724000041/cmtl-20240131.htm" STYLE="-sec-extract: exhibit">March&#8239;22, 2024</A>) and (iii)&#8239;October&#8239;31,
2023, as filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319723000070/cmtl-20231031.htm" STYLE="-sec-extract: exhibit">December&#8239;7, 2023</A>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD>Our Current Reports on Form&#8239;8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319723000040/cmtl-20230824.htm" STYLE="-sec-extract: exhibit">August&#8239;28, 2023</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000110465923115298/tm2330121d1_8k.htm" STYLE="-sec-extract: exhibit">November&#8239;7, 2023</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000095014223002964/eh230430442_8k.htm" STYLE="-sec-extract: exhibit">December&#8239;14, 2023</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319723000077/cmtl-20231214.htm" STYLE="-sec-extract: exhibit">December&#8239;18, 2023</A> (as amended on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319723000084/cmtl-20231214.htm" STYLE="-sec-extract: exhibit">December&#8239;22, 2023</A>), <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319724000006/cmtl-20240103.htm" STYLE="-sec-extract: exhibit">January&#8239;9, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000095014224000193/eh240440684_8k.htm" STYLE="-sec-extract: exhibit">January&#8239;22, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000095014224000204/eh240441119_8k.htm" STYLE="-sec-extract: exhibit">January&#8239;23, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000095014224000665/eh240457604_8k.htm" STYLE="-sec-extract: exhibit">March&#8239;13, 2024</A>,
<A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319724000021/cmtl-20240311.htm" STYLE="-sec-extract: exhibit">March&#8239;15, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319724000061/cmtl-20240327.htm" STYLE="-sec-extract: exhibit">April&#8239;1, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000121390024039189/ea0205180-8k_comtech.htm" STYLE="-sec-extract: exhibit">May&#8239;2, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000095014224001650/eh240496292_8k.htm" STYLE="-sec-extract: exhibit">June&#8239;18, 2024</A>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD>Our Definitive Proxy Statement on Schedule 14A, filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319723000056/cmtl-20231116.htm" STYLE="-sec-extract: exhibit">November&#8239;16, 2023</A>, and the accompanying additional proxy
materials filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/23197/000002319723000061/a12-05x2023definitiveproxy.htm" STYLE="-sec-extract: exhibit">December&#8239;5, 2023</A>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon written or oral request, we will provide without
charge to each person, including any beneficial owner, to whom a copy of the prospectus is delivered a copy of the documents incorporated
by reference in this prospectus (other than exhibits to such documents unless such exhibits are specifically incorporated by reference
in this prospectus). You may request a copy of these filings, at no cost, by writing or telephoning us at the following address: Comtech
Telecommunications Corp., 305 N 54th Street, Chandler, Arizona 85226, c/o Investor Relations, telephone: (480) 333-2200. You may also
access these documents on our website at <I>www.comtech.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Information on our website, including subsections,
pages, or other subdivisions of our website, or any website linked to by content on our website, is not part of this prospectus and you
should not rely on that information unless that information is also in this prospectus or incorporated by reference in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 1,435,884 shares of Common Stock underlying
the Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2419253d1_s1img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Comtech Telecommunications Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&#8239;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&#8239;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">July 23, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence -->&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2419253d1_s1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2419253d1_s1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# 00# 2(  A$! Q$!_\0
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MU&W)W/!Q]:I4KR4Y-V?5CJ***S. **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2419253d1_s1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2419253d1_s1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !4 3(# 2(  A$! Q$!_\0
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MP .HHHH _FV_X.)?CQ)X6^"OPE_9[T>[FM]0^+7B^[\5^(FM;D1&3P=\/[>
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M]SIZ:D;$7,%A,]N9;.._&GP#4X(KN*U=D1KA)$8%/X@O^"QWBGQM_P %-O\
M@N[^R-_P1H3Q)X@TO]E7X?#P9\4OVC?!GA;5GTH^+-6M?"7B#XS>++GQ%?13
M>4EQH7P;@T'P[\/CJ*BU\*^(?&6L7^FPW-S>Z:C@'U]X)_X+M?\ !33_ (*%
M2ZOK7_!'W_@EE'\1?@_X:UBYT&7]H/\ :Q\?Z!X&\-Z[?6>W[=8:3X=@^(G@
MK3_MUJ7"WMIH7Q8\;W%JV4N8HF!!A^(7_!:S_@LC^P'8CQY_P5"_X)->%?\
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M#?B"R@ANK[PGXI\/32_VIH7B.SADAN+O1-1AAU"V@ECD>!(I(WKX7_X*X_\
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MJ2 ,YK^6[_@W&_;L\>ZUX$^(/_!*S]KN2_T+]MK_ ()]7NJ?#Z?2];>>YO\
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M]AOP]^V?>^*9O&\'Q7BU_P")GAOX<K\.H=)/@O\ X1*6U'B/Q-X2'B#_ (3
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M>+_BYXZ^!OPE\9?'WX;VOP;^,WB?P)X<UCXG_"O3M?MO$MIX \;:IIHN=?\
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M=& :$1OY@78V/J?4O%GA@6%[_P 5'H.39WH _MC3\G<"$Q_I'.X?='\7 &:
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MP^\&W2N^(-<N-9T>7%\DD%=1_P '9-V)OBA_P1?\,QD%]7_;$UV]CAR"LO\
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MB^([ 75I'XATJ&>X@TJ[GM0NGZGIEFEPT4A>)EC/F9 /YVO^#03XM^&/&?\
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MVK&1_,"#W"Y_X,P/^"9-O;W$R_M"?M]/,MLYQ)\5/V?_ "?D'S$X_97;A>_
MVY)(';^D3]@!'M_V$OV++6=&AN;;]DC]G"UN+>53'/!<VOP>\(V]S;S0N%DB
MGMYX9H)X759(9HI(Y%5T91]6:A_QY78[M:7JJ/[S./E4>I;^$#D]LT ?Q<?\
M&3L<=O\ LA_MIP1,QBA_:@\/HAEXD)7X6:(KJ01G<N/F!Y'.>2:_M9K^+?\
MX,N-(U71_P!E']M.WU?3-0TJXG_:ET^X@@U&RN;&::"+X<:39R3Q17,43R0Q
MW<,UJ\B*42XBD@9A*C*/[2* "BBB@#F-:T33-?TS4='URSMM1TS6;&XT_5-/
MNH?.L[^VO+5["^L[B.12K6ES Q5E9<.I;.5-?PI_\%7_ /@G--^QG\5!XV\"
M:-K%S^SA\2KZ\G\,706YU"P^'WB;RGCU'P;K.H(DBPVMQ"TB>"Y;N:%H=(C?
M2;DR:J&\S^\IXO,!)!!'L>>>V?Y>^<] .%\5>"O#?CS0-7\)^+_#VE>(O#.M
MZ<+'5M$\0Z9#JVE:I:M&,6U_:7,,AOH 201<"&\!4C=\QK]C\%O&//O!WB?^
MV,'AH9QD.-5+#\1<-XF:6&S;!4I34'33;C3S+"1KUYY?BFDZ$JE6*DE59^V^
M OCKQ-X&<8T\^R]1S+)\1+#4,\X>Q,ZBP6;X6FZO+)4HWI2S3!QJUY9;4Q$?
M8TYU:L*C5.JS^ S]AK_@I9\=?V(=9%AX6DA\8?"'5-7GN=<^$>M2S+H$4]YD
MW^K>&-0;YO!VI7)(;R;-;C29V!?[.&)(_K$_9M_X+%_L7_'K1X)=3^)ND_!7
MQ(J8O?"?QFUC2/"%S%(0<+IVM7-W%X8U< @[9-/U"\7D%\9P/R8_; _X-_/&
M#:MXG\;_ +(WB32]0T:^N3?VOP9\:,=.U32(F4%[+POXWN/+TS57S\L>C^(C
M96S,SM+XP5*_ [XU?LH_M,?L[AI_C%\$O'WPXL)95AM?$5]H<\WAZXN).1!8
M>(=)M[CP;<38Y^SQZO)*,$",$$5_47&>2?1_\<E5XEX3S=Y)Q%CZ7M<;@JE6
MAA*F$KSBG# U:.(>&JXG$X6<*\:^,A"I&NN24*\N1-?Z69KP%]$;Z7T:'$N
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M;XN:?;Z'\5OAEX!^)FD6[^=;Z=X_\):#XOLX)=P'F16_B"QU"*-P#@,J @<
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J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
